Compare Boston Scientific Corporation (BSX) vs FirstEnergy Corp. (FE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs FirstEnergy Corp. — how do they compare? Boston Scientific Corporation trades at $42.65 (market cap $66.37B), while FirstEnergy Corp. trades at $49.5 (market cap $28.01B). The key difference: Boston Scientific Corporation is far larger — about 2.4× FirstEnergy Corp.'s market cap, and FirstEnergy Corp. pays a 3.84% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | FE | |
|---|---|---|
Market Cap | $66.37B | $28.01B |
Sector | Health | Utilities |
52-Week High | $108.14 | $51.91 |
52-Week Low | $42.63 | $40.30 |
Enterprise Value | $75.94B | $56.02B |
Dividend Yield | — | 3.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Boston Scientific (BSX) trades at $44.65, down 0.27% with bearish technical signals despite strong fundamentals. The company delivered three consecutive earnings beats with Q3-Q1 2026 EPS exceeding expectations, while revenue grew to $20.07B in 2025 with improving profit margins. Technical indicators show bearish momentum with support at $44 and resistance at $45, though Wall Street maintains 88% buy rating with $70.20 consensus target.
BSX presents a compelling value opportunity with attractive valuation multiples (P/E 18.68, P/S 3.24) and robust financial health, though near-term headwinds include competitive pressures in key segments and recent stock price decline of nearly 60% from 2025 highs. The strong analyst consensus suggests significant upside potential if execution improves.
FirstEnergy Corp. (FE) trades at $48.43, up 1.06% on the day, with a bullish technical signal supported by moving averages. The stock shows steady revenue growth, reaching $15.09B in 2025, and maintains a net income margin of 6.86%. Analyst consensus is a Buy with a $52.00 price target, reflecting optimism around grid investments and data center demand. Recent news highlights FE's strategic positioning amid rising energy needs and infrastructure upgrades.
Outlook is positive due to strong fundamentals and growth initiatives, but risks include high debt levels and regulatory pressures. The stock offers potential upside from current levels, supported by earnings beats and institutional confidence, though investors should monitor cash flow trends and execution of capital expenditures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About FirstEnergy Corp.
FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.
Read more on FE →
